Skip to content

Feed Screener MCP Methodology

⌘K

EN

Pricing Sign in

InsiderLens

Public insider filings, with historical context.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
AMF · FR
BAFIN · DE

Product

Recent insider buying
Cluster buys
How to read a Form 4
Ask the record
Help
About InsiderLens
Methodology
Signal backtests
Terms
Privacy notice
Object to processing

Language

English Español Français

MiNeng, Inc. — Bambusa Therapeutics, Inc. insider · InsiderLens

Feed Screener MCP Methodology

Pricing Sign in

English Español Français

MiNeng, Inc.

FollowCreate a free account to set a filing alert.

10% owner at · on record since Oct 29, 2026

Track record of MiNeng, Inc.

Insufficient history for a statistical track record (fewer than 5 purchases).

Transaction history of MiNeng, Inc.

Co-insiders of MiNeng, Inc.

This page republishes public regulatory disclosures.

/ / MiNeng, Inc.

Insider trading activity of MiNeng, Inc.

No transactions on record for MiNeng, Inc..

Bambusa Therapeutics, Inc.

DiRocco DerekBambusa Therapeutics, Inc.

Foerster Christian UweBambusa Therapeutics, Inc.

Ho Minh Quoc ThangBambusa Therapeutics, Inc.

Jeggle Helmut WolfgangBambusa Therapeutics, Inc.

Kolchinsky PeterBambusa Therapeutics, Inc.

Liang HowardBambusa Therapeutics, Inc.

Lieber Jonathan IBambusa Therapeutics, Inc.

RA Capital Biotech Fund LPBambusa Therapeutics, Inc.

RA CAPITAL MANAGEMENT, LLCBambusa Therapeutics, Inc.

RA Capital Nexus Fund III, L.P.Bambusa Therapeutics, Inc.

Salvia Investment GmbHBambusa Therapeutics, Inc.

Shah Rajeev M.Bambusa Therapeutics, Inc.

Xu ShanshanBambusa Therapeutics, Inc.

Concerned by this data? Exercise your right to object →

No transactions on record.